Increased bacterial adherence and biomass in Pseudomonas aeruginosa bacteria exposed to clarithromycin

Diagnostic Microbiology and Infectious Disease

Volumn 63, Issue 1, 2009, Pages 81-86

  Garey, Kevin W ^a,b   Vo, Quynh P ^a   Lewis, Russell E ^a   Saengcharoen, Woranuch ^c   LaRocco, Mark T ^b   Tam, Vincent H ^a,b  

^a UNIVERSITY OF HOUSTON   (United States)

^b ST LUKE S EPISCOPAL HOSPITAL   (United States)

^c PRINCE OF SONGKLA UNIVERSITY   (Thailand)

Author keywords

Biofilms; Clarithromycin; Macrolides; P. aeruginosa

Indexed keywords

CLARITHROMYCIN;

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM ADHERENCE; BIOFILM REACTOR; DRUG MECHANISM; MICROBIAL BIOMASS; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ANALYSIS OF VARIANCE; ANTI-BACTERIAL AGENTS; BACTERIAL ADHESION; BIOFILMS; BIOMASS; CLARITHROMYCIN; COLORIMETRY; DOSE-RESPONSE RELATIONSHIP, DRUG; PSEUDOMONAS AERUGINOSA;

EID: 57349123991     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2008.09.007     Document Type: Article

References (23)

1. Bader M.W., Navarre W.W., Shiau W., Nikaido H., Frye J.G., McClelland M., Fang F.C., and Miller S.I. Regulation of Salmonella typhimurium virulence gene expression by cationic antimicrobial peptides. Mol. Microbiol. 50 (2003) 219-230
2. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. 17th informational supplement M100-S17 (2007), CLSI, Wayne, PA
3. Costerton J.W., Stewart P.S., and Greenberg E.P. Bacterial biofilms: a common cause of persistent infections. Science 284 (1999) 1318-1322
4. Favre-Bonte S., Kohler T., and Van Delden C. Biofilm formation by Pseudomonas aeruginosa: role of the C4-HSL cell-to-cell signal and inhibition by azithromycin. J. Antimicrob. Chemother. 52 (2003) 598-604
5. Garey K.W., Alwani A., Danziger L.H., and Rubinstein I. Tissue reparative effects of macrolide antibiotics in chronic inflammatory sinopulmonary diseases. Chest 123 (2003) 261-265
6. Gillis R.J., and Iglewski B.H. Azithromycin retards Pseudomonas aeruginosa biofilm formation. J. Clin. Microbiol. 42 (2004) 5842-5845
7. Goh E.B., Yim G., Tsui W., McClure J., Surette M.G., and Davies J. Transcriptional modulation of bacterial gene expression by subinhibitory concentrations of antibiotics. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 17025-17030
8. Herigstad B., Hamilton M., and Heersink J. How to optimize the drop plate method for enumerating bacteria. J. Microbiol. Methods 44 (2001) 121-129
9. Hoffman L.R., D'Argenio D.A., MacCoss M.J., Zhang Z., Jones R.A., and Miller S.I. Aminoglycoside antibiotics induce bacterial biofilm formation. Nature 436 (2005) 1171-1175
10. Imamura Y., Yanagihara K., Mizuta Y., Seki M., Ohno H., Higashiyama Y., Miyazaki Y., Tsukamoto K., Hirakata Y., Tomono K., Kadota J., and Kohno S. Azithromycin inhibits MUC5AC production induced by the Pseudomonas aeruginosa autoinducer N-(3-oxododecanoyl) homoserine lactone in NCI-H292 Cells. Antimicrob. Agents Chemother. 48 (2004) 3457-3461
11. Mizukane R., Hirakata Y., Kaku M., Ishii Y., Furuya N., Ishida K., Koga H., Kohno S., and Yamaguchi K. Comparative in vitro exoenzyme-suppressing activities of azithromycin and other macrolide antibiotics against Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 38 (1994) 528-533
12. Nagata T., Mukae H., Kadota J., Hayashi T., Fujii T., Kuroki M., Shirai R., Yanagihara K., Tomono K., Koji T., and Kohno S. Effect of erythromycin on chronic respiratory infection caused by Pseudomonas aeruginosa with biofilm formation in an experimental murine model. Antimicrob. Agents Chemother. 48 (2004) 2251-2259
13. Nalca Y., Jansch L., Bredenbruch F., Geffers R., Buer J., and Haussler S. Quorum-sensing antagonistic activities of azithromycin in Pseudomonas aeruginosa PAO1: a global approach. Antimicrob. Agents Chemother. 50 (2006) 1680-1688
14. O'Toole G.A., Pratt L.A., Watnick P.I., Newman D.K., Weaver V.B., and Kolter R. Genetic approaches to study of biofilms. Methods Enzymol. 310 (1999) 91-109
15. Rodvold K.A., Gotfried M.H., Danziger L.H., and Servi R.J. Intrapulmonary steady-state concentrations of clarithromycin and azithromycin in healthy adult volunteers. Antimicrob. Agents Chemother. 41 (1997) 1399-1402
16. Rowe S.M., Miller S., and Sorscher E.J. Cystic fibrosis. N. Engl. J. Med. 352 (2005) 1992-2001
17. Saiman L. The use of macrolide antibiotics in patients with cystic fibrosis. Curr. Opin. Pulm. Med. 10 (2004) 515-523
18. Saiman L., Marshall B.C., Mayer-Hamblett N., Burns J.L., Quittner A.L., Cibene D.A., Coquillette S., Fieberg A.Y., Accurso F.J., and Campbell III P.W. Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial. JAMA 290 (2003) 1749-1756
19. Stoodley P., and Warwood B.K. Use of flow cells and annular reactors to study biofilms. In: Lens P., O'Flaherty V., Moran A., Stoodley P., and Mahony T. (Eds). Biofilms in industry, medicine, and environmental biotechnology-characteristics, analysis, and control (2003), IWA Publishing, London
20. Tateda K., Ishii Y., Matsumoto T., Kobayashi T., Miyazaki S., and Yamaguchi K. Potential of macrolide antibiotics to inhibit protein synthesis of Pseudomonas aeruginosa: suppression of virulence factors and stress response. J. Infect. Chemother. 6 (2000) 1-7
21. Wozniak D.J., and Keyser R. Effects of subinhibitory concentrations of macrolide antibiotics on Pseudomonas aeruginosa. Chest 125 (2004) 62S-69S (quiz 69S)
22. Yasuda H., Ajiki Y., Koga T., Kawada H., and Yokota T. Interaction between biofilms formed by Pseudomonas aeruginosa and clarithromycin. Antimicrob. Agents Chemother. 37 (1993) 1749-1755
23. Zelver N., Hamilton M., Pitts B., Goeres D., Walker D., Sturman P., and Heersink J. Measuring antimicrobial effects on biofilm bacteria: from laboratory to field. Methods Enzymol. 310 (1999) 608-628